MyFinsight
Home
Blog
About
Contact
Download
Download image
Collaborative Arrangements
Linzess
$104,223K
Royalty
$887K
Abbvie
Plc-Collaborative Arrangement...
$105,110K
(166.82%↑ Y/Y)
Abbvie
Plc-Collaborative Arrangement...
$808K
(-0.37%↓ Y/Y)
Astellas Pharma
Inc-Collaborative Arrangement...
$347K
(-6.97%↓ Y/Y)
Asahi Kasei Pharma
Corporation-Collaborative Arrangement...
$162K
(-66.04%↓ Y/Y)
Astra
Zeneca-Collaborative Arrangement...
$79K
(-10.23%↓ Y/Y)
Total revenues
$106,506K
(158.87%↑ Y/Y)
Income (loss) from
operations
$72,573K
(349.32%↑ Y/Y)
Total costs and
expenses
$33,933K
(-51.70%↓ Y/Y)
Restructuring, net
-$40K
(-100.22%↓ Y/Y)
Income (loss) before
income taxes
$65,172K
(279.68%↑ Y/Y)
Other income
(expense), net
-$7,401K
(-3.31%↓ Y/Y)
Interest and investment
income
$1,698K
(95.40%↑ Y/Y)
Other
$42K
(13.51%↑ Y/Y)
Research and development
$21,940K
(-20.02%↓ Y/Y)
Selling, general and
administrative
$12,033K
(-50.40%↓ Y/Y)
Net income (gain)
$40,773K
(209.06%↑ Y/Y)
Income tax expense
$24,399K
(2090.22%↑ Y/Y)
Interest expense and
other financing costs
$9,141K
(13.27%↑ Y/Y)
Back
Back
Income Statement
IRONWOOD PHARMACEUTICALS INC (IRWD)
IRONWOOD PHARMACEUTICALS INC (IRWD)
source: myfinsight.com